Gates Foundation announces $40m funding to advance mRNA-based vaccines
The Bill & Melinda Gates Foundation will provide $20m to Quantoom Biosciences to further advance the mRNA technology,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Oct 23
The Bill & Melinda Gates Foundation will provide $20m to Quantoom Biosciences to further advance the mRNA technology,…
10 Oct 23
In the trial, patients treated with Vabysmo extended their treatment intervals up to every four months while maintaining…
10 Oct 23
The biotechnology firm intends to use the funds to develop its proprietary technology platform and expedite the development…
10 Oct 23
The facility has been designed to accommodate a second module of production suites, which will play a crucial…
10 Oct 23
According to the Smidge, the product is designed to offer essential nutrients lacking in even the best whole…
10 Oct 23
The partnership will substantially enhance the accessibility of Shingrix in China, as it involves joint promotion to healthcare…
10 Oct 23
Oregovomab is a murine monoclonal antibody
10 Oct 23
Strategic Financial Sponsor to Support Continued Growth and Market Expansion
09 Oct 23
Through the acquisition, BMS will add Mirati’s lung cancer drug Krazati to its commercial portfolio, along with several…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Oct 23
The deal has secured clearance from the US Federal Trade Commission which prohibits Amgen from using any anti-competitive…